|
HS Code |
716069 |
| Chemical Name | Triazolopyrimidinone |
| Molecular Formula | C5H3N5O |
| Molecular Weight | 149.11 g/mol |
| Appearance | White to off-white crystalline powder |
| Melting Point | 275-277°C |
| Solubility In Water | Slightly soluble |
| Boiling Point | Decomposes before boiling |
| Cas Number | 5521-55-1 |
| Functional Groups | Triazole, Pyrimidinone |
| Density | Approx. 1.60 g/cm³ |
| Logp | -0.17 |
| Stability | Stable under normal storage conditions |
As an accredited Triazolopyrimidinone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical Triazolopyrimidinone is supplied in a 25g amber glass bottle, securely sealed, featuring hazard warnings and product labeling. |
| Shipping | Triazolopyrimidinone should be shipped in tightly sealed containers, protected from light and moisture, and stored at room temperature. Compliant with relevant regulations, the shipment must include proper labeling and documentation. Avoid contact with incompatible substances. Handle according to safety protocols to ensure safe transportation and delivery. |
| Storage | Triazolopyrimidinone should be stored in a tightly sealed container, away from light, moisture, and incompatible substances. Keep it in a cool, dry, and well-ventilated area, ideally under an inert atmosphere such as nitrogen or argon if the substance is sensitive to air. Ensure storage in accordance with local regulations and label the container clearly for identification and safety. |
|
Purity 99%: Triazolopyrimidinone with purity 99% is used in pharmaceutical intermediate synthesis, where high chemical yield and consistent product quality are achieved. Melting Point 215°C: Triazolopyrimidinone with melting point 215°C is used in active pharmaceutical ingredient formulation, where thermal stability during processing is ensured. Stability Temperature 120°C: Triazolopyrimidinone at stability temperature 120°C is used in agrochemical formulations, where long-term efficacy under field conditions is maintained. Molecular Weight 180.16 g/mol: Triazolopyrimidinone with molecular weight 180.16 g/mol is used in medicinal chemistry research, where precise dosage and metabolic profiling are enabled. Particle Size <10 µm: Triazolopyrimidinone with particle size less than 10 µm is used in solid dispersion techniques, where dissolution rate and bioavailability are improved. Solubility in DMSO 50 mg/mL: Triazolopyrimidinone with solubility in DMSO 50 mg/mL is used in in vitro screening assays, where accurate compound delivery and reproducible results are supported. Assay ≥98%: Triazolopyrimidinone with assay ≥98% is used in fine chemical manufacturing, where product purity and consistency are critical for downstream processes. Storage Condition 2-8°C: Triazolopyrimidinone with storage condition 2-8°C is used in analytical laboratory settings, where compound integrity and shelf life are preserved. |
Competitive Triazolopyrimidinone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Sometimes, behind the scenes in labs and research centers, a single compound shifts the conversation. Triazolopyrimidinone has caught the attention of chemists, pharmaceutical scientists, and even agriculturists for good reason. Over the years, the chemistry community has chipped away at molecular puzzles, each fragment opening the door to better medicines, more precise crop solutions, or new materials. Triazolopyrimidinone stands out because of the unique way its backbone blends the triazole and pyrimidine rings, unlocking chemical properties others rarely match.
Diving into its structure, Triazolopyrimidinone offers a solid foundation for design flexibility. Having spent years poring over chromatograms and NMR spectra, I’ve seen how even minor tweaks on ring systems can tip the balances of stability, solubility, and binding. This molecule's scaffold lets researchers swap substituents without unraveling the core. It tolerates changes at key positions, often impacting its biological activity or compatibility with various solvents.
From personal experience, many candidate compounds hit performance walls—either too finicky to synthesize or too unpredictable in a biological setting. Triazolopyrimidinone sidesteps these headaches thanks to its robust architecture. It takes well to standard synthetic methods, including common cyclization routes or nucleophilic substitutions. This means labs—whether in academia or industry—don’t have to overhaul their toolkits just to work with it.
Over the last decade, scientists searching for new drug molecules keep circling back to nitrogen-rich heterocycles. This isn’t a fad. The triazole and pyrimidinone moieties in this compound are well-represented in various antiviral, antifungal, and even anticancer candidates. Both rings play nicely with hydrogen-bonding sites and interact with enzymes, receptors, or nucleic acids.
Unlike simpler heterocycles, Triazolopyrimidinone allows for a richer profile of aromatic stacking and hydrogen-bond donor/acceptor arrangements. In one project, colleagues used it as a building block for enzyme inhibitors, and it showed both strong receptor binding and solid metabolic stability in early screening. That’s not something you see every day with freshly synthesized scaffolds.
In crop science, researchers have found antimicrobial and plant growth modulation effects. Sometimes, adjusting a substituent on the triazole ring produces sharp changes in activity against problematic pathogens. The versatility means companies can keep chasing new leads for both pharmaceutical and agricultural applications instead of being boxed into a single-purpose compound.
It’s easy to get swept up by hype. But in real lab work, only compounds with clear, reproducible specifications make the cut. For Triazolopyrimidinone, crystalline forms dominate—most commonly as fine, off-white powders. Purity specs often run 98% or greater by HPLC—nothing less flies for reputable research. Melting points range widely, depending on the attached groups, but most sit comfortably above room temperature, giving decent shelf stability. Most forms resist hydrolysis under ambient conditions, so storage in typical desiccants suffices.
Because of its heterogeneous nature, commercial supplies often reflect small differences in manufacturing routes. Batch-to-batch consistency can be tracked through spectroscopic fingerprints, mostly relying on proton NMR shifts in key aromatic regions. From my experience, suppliers willing to share their spectral overlays leave less room for quality surprises. Solubility checks, particularly in DMF, DMSO, or even standard ethanol, round out the usual battery of tests. These details are not dry trivia: a slight slip in purity or crystal form could disrupt an entire synthetic sequence or lead to false data in bioassays.
Most of my time in lab coats saw me working with similar heterocycles, and the real sign of a compound’s value is how it holds up between theory and practice. Triazolopyrimidinone steps up as a linker, a core scaffold, or even a pharmacophore to tack on functional groups. Researchers don’t have to navigate tricky protection-deprotection strategies—most reactions move forward smoothly, especially C- or N-alkylation steps.
For those in drug design, introducing Triazolopyrimidinone into a candidate molecule injects rigidity and planarity, which are often required for tight protein binding. In practice, I’ve seen research teams use these compounds as starting points for computational docking, since the geometry fits naturally into active sites without convoluted modeling. This isn’t just theoretical; startups and pharma giants alike have thrown resources at libraries featuring this scaffold, hoping to snag the next blockbuster.
Beyond medicine, the scope widens. As a building block for agrichemicals, it brings resilience to pesticide designs, helping them weather UV and microbial breakdown. Formulations don’t degrade overnight, which helps with regulated field trials. Then there are specialty polymers and material science pursuits: the multiple nitrogen atoms lend unique conductivity and electron transfer properties, lighting up research into sensors and organic semiconductors.
From my vantage point, even educators appreciate having a compact, moderately safe heterocycle for undergraduate synthesis drills. The reaction steps rarely need harsh conditions, and students gain hands-on experience with crystallization, TLC monitoring, or spectrum interpretation.
Plenty of nitrogen-based heterocycles line the shelves. Pyrimidines get much attention in basic biochemistry circles—look at DNA, after all. Triazoles bring flexible reactivity, essential for “click” chemistry or linking sugars and peptides. What Triazolopyrimidinone does is marry both without inheriting their weaknesses.
Pyrimidinones alone can lack diversity in reactivity for follow-up chemistry, and triazoles sometimes introduce stability limits. With both, Triazolopyrimidinone keeps a foot in two camps—broadening what can get attached and how easily those modifications update the molecule’s profile. Every researcher has run into heterocycles that won’t stay put under basic or acidic workup conditions. This hybrid has shown a knack for withstanding a broader range of reagents, which saves time and resources.
Compared to other scaffolds, its electron density stands out. This difference comes through strongly during aromatic substitutions or in electrophilic attacks. In several collaborative projects, we watched as its reactivity let medicinal chemists decorate the ring in ways that stubborn benzene rings couldn’t handle. The resulting diversity is incredibly valuable once screening campaigns shift towards optimizing a lead compound’s properties for absorption or metabolic stability.
While analogs like benzotriazoles or quinazolines offer good chemical tools, neither hits the same winning combination of rigidity, tunable electronics, and ease-of-use. In many medicinal chemistry circles, that trifecta is rare enough to call attention. My own notebooks bear the scrawls of failed attempts trying to drag lesser scaffolds through multi-step sequences—Triazolopyrimidinone often made those workflows manageable.
Triazolopyrimidinone doesn’t solve every synthesis or application. Large-scale production cost can be higher, especially when fine-tuning substituents for a niche project. Certain functional groups demand more demanding conditions or sensitive handling. These aren’t problems unique to this scaffold, but they crop up during scale-ups or when regulatory pressures tighten (especially with pharmaceuticals).
The environmental impact of production routes still inspires discussion. Waste solvents or reagents, particularly in “small molecule” chemistry, persist as real hurdles. Labs are moving toward greener protocols, using catalytic processes or solvent swaps. In my own time, switching out classical chlorinated solvents for water or bio-based alternatives hasn’t always kept yields intact, though incremental change still beats the old ways.
Then there’s the challenge of selectivity in downstream modifications. Adding more complex groups to the rings sometimes triggers side reactions. Some experienced hands, myself included, have spent evenings troubleshooting reaction mixtures that didn’t read the textbook. Yet having a solid scaffold helps—many small changes to the synthesis plan still land competitive yields.
Quality assurance looms. The best compounds in the world lose value if researchers can’t confirm their identity and purity. It helps that Triazolopyrimidinones’ analytical fingerprints are easy to spot on NMR or mass spec, but QC branches need to stay vigilant as this area grows. Poor-quality supplies can torpedo whole research projects. I learned early not to cut corners—one unlucky procurement run taught my team the cost of chasing bargains in specialty chemicals.
Unlocking the full value of Triazolopyrimidinone for both science and industry comes down to accessibility. Broadening the field beyond specialist manufacturers would lower costs and encourage wider screening in new chemical spaces. As high-throughput robotics and parallel synthesis start driving discovery, this compound is perfectly placed to seed new molecular libraries.
For producers, transparent specification sheets and shared NMR/IR/MS data let buyers verify quality before they order. This not only wards off substandard supplies but also builds trust. Researchers, particularly those in startup labs with tight budgets, rely on access to well-characterized lots. Packaging options, from small milligram vials to bulk kilogram bins, further help accommodate a range of users—from academic projects to full-scale industrial runs.
Another area ripe for improvement is responsible sourcing and waste management. Seen from the ground, every research group wants progress without environmental headaches. Shifting toward recyclable solvents or closed-loop systems during production will mean a bit more upfront work, but the payoff in reduced hazardous waste is real. Over time, industry groups will likely accelerate adoption of best practices—regulators could help by providing guidance instead of after-the-fact penalties.
Education matters, too. Triazolopyrimidinone rarely appears in basic organic textbooks, even if its parent rings do. Integrating real-world case studies of its use in medicines, crop protection, or polymers into curricula would prepare the next generation of chemists. At campus workshops, seeing a robust heterocycle run through its paces could spark more creative applications—something desperately needed as traditional leads dry up.
Setting aside chemical specifics, molecules like Triazolopyrimidinone play a quiet but crucial role in health and sustainability. The search for new antivirals or cancer therapies depends on constant iteration and new scaffolds. With resistance patterns shifting and environmental regulations tightening, industry and academia must move beyond comfortable old standbys.
Access to robust, modifiable molecules is a linchpin for medical innovation. Triazolopyrimidinone checks those boxes with a balance of chemical resilience and functionalization potential. These qualities show up time and again in medicinal chemistry reports, where novel enzyme inhibitors or therapeutic candidates hinge on subtle tweaks to the core scaffold. As public expectations for safe, effective, and affordable medicines rise, compounds like this one help answer the call.
Looking outward, agriculture’s needs for safe and durable crop protection solutions are growing. Innovation in this arena has stalled in many countries because development pipelines lean on outdated chemistries. Triazolopyrimidinone offers tangible hope for new plant health agents that last in the field without creating residues. Often, the right blend of scientific creativity and practical design opens new possibilities, supporting both food security and environmental stewardship.
Specialty polymers and advanced materials sometimes need more than just inert backbones. Here, Triazolopyrimidinone’s ability to shuttle electrons or anchor redox-active groups fits the script, powering new types of electronics or medical devices. The ongoing shift toward sustainable, high-performance materials can benefit from heterocycles just as much as small-molecule pharma does.
Nobody works in a vacuum. Open lines between suppliers, researchers, regulators, and end-users will move Triazolopyrimidinone from niche to mainstream. Lessons from the past have shown that transparency around composition, performance, and safety win trust and unlock adoption. Publications, data repositories, and collaborative consortia can help map both best practices and pitfalls, steering discovery toward higher impact.
Affordable, reliable supply chains make big differences. As more facets of research probe Triazolopyrimidinone’s performance, economies of scale should kick in. This can lower prices and let bootstrapped research teams test new hypotheses. Community-driven monitoring—lab forums, peer-reviewed case studies, frank vendor reviews—lets red flags surface before they sting downstream.
Lasting progress isn’t only about faster synthesis or new applications; it’s about responsibility. Keeping eyes on material lifecycles, toxicity data, and end-of-use disposal will stop today’s solutions from becoming tomorrow’s problems. These checks mean more up-front work, but reputations in science and industry now hinge on stewardship, not just output.
Step by step, thriving collaborations between the public and private sectors promise a bright future. Academic research often picks up where industry tapers off, exploring blue-sky applications that may feed back into new products or processes. Global networks connecting universities, startups, farm co-ops, and multinational companies can break the silos that sometimes slow innovation. My own experience proves that every major leap, from bench to market, came from borrowing hard-won wisdom outside my specialty.
Chemistry often advances in measured steps, not thunderclaps. Yet, with robust scaffolds like Triazolopyrimidinone, progress comes a little easier. Researchers, educators, and industry insiders should see in it not just another compound, but a well-built platform for drug discovery, crop protection, and advanced material science.
Staying grounded, I’ve learned that real advances depend on more than theoretical promise—they lean on reliability, adaptability, and open information flow. Whether it’s the night shift in a research lab or a test plot in the field, these qualities shape results. When shared knowledge and practical experience meet, Triazolopyrimidinone can help tip the scales toward better solutions that last.